You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

brca status

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

BRCA and NACT in TNBC Patients

Completed
  • Triple-Negative Breast Cancer
  • BRCA1/2 genetic testing
  • Rome, RM, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Feb 20, 2023

Ultra-rapid BRCA1/2 Status Screening Test in Theranostic

Not yet recruiting
  • Breast Cancer
  • Questionnaires
  • Communication of the results of the BRCA1/2 ultra rapid test
  • (no location specified)
Oct 26, 2023

Breast Cancer With or Without BRCA Mutation

Recruiting
  • Breast Cancer
  • Androgen receptor status and BRCA mutation
  • Varanasi, UP, India
    Banaras Hindu University
Jun 2, 2022

Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt

Not yet recruiting
  • Advanced Ovarian Cancer
  • None (Observational Study)
  • (no location specified)
Mar 8, 2023

Prevalence of BRCA in Patients With Ovarian Cancer

Completed
  • BRCA Status
  • Ovarian Cancer
  • Testing of BRCA status regarding germline and somatic mutation
  • Berlin, Germany
  • +19 more
Jun 11, 2021

Impact of Positive BRCA1/2 Mutation Status on Lives of Young

Completed
  • BRCA1 Gene
  • BRCA2 Gene
    • Bethesda, Maryland
      National Cancer Institute (NCI), 9000 Rockville Pike
    Nov 26, 2021

    HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer

    Completed
    • Epithelial Ovarian Cancer
    • +6 more
    • Evaluation of homologous recombination deficiency score
    • Beijing, Beijing, China
      Lei Li
    Mar 26, 2022

    Capturing BRCA1/2 Mutational Status in High Grade Serous Ovarian

    Active, not recruiting
    • Ovarian Cancer
    • BRCA genetic data
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Sep 29, 2021

    ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer, a Germline or Somatic BRCA Mutation, or a

    Recruiting
    • ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer
    • a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI Status
    • Montpellier, France
    • +1 more
    Nov 16, 2022

    China Ovarian Cancer BRCA Testing Study

    Terminated
    • Ovarian Cancer
      • Hefei, Anhui, China
      • +18 more
      Oct 13, 2020

      A Training Set for the HRD Model in EOC

      Recruiting
      • Epithelial Ovarian Cancer
      • +5 more
      • Homologous recombination deficiency model
      • Beijing, Beijing, China
        Lei Li
      Dec 2, 2020

      PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES

      Not yet recruiting
      • BRCA Mutation
      • +2 more
      • Germinal BRCA
      • (no location specified)
      Mar 3, 2023

      IMpact of Breast cAncer Gene Status on Survival in Adjuvant

      Completed
      • Breast Cancer
      • +2 more
      • BRCA mutation
      • Besançon, Franche-Comté, France
        University Hospital Jean Minjoz
      Jul 8, 2019

      Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity Trial in Canada, United States (OLAPARIB)

      Completed
      Has Results
      • Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity
      • Anchorage, Alaska
      • +46 more
      Mar 22, 2022

      Homologous Recombination Deficiency Status in Epithelial Ovarian

      Unknown status
      • Epithelial Ovarian Cancer
      • +5 more
      • Genomic testing
      • Beijing, Beijing, China
        Lei Li
      Dec 6, 2019

      Advanced Breast Cancer Trial in Spain (Olaparib [Lynparza®] plus Trastuzumab [Herceptin®])

      Terminated
      • Advanced Breast Cancer
      • Olaparib [Lynparza®] plus Trastuzumab [Herceptin®]
      • Barcelona, Spain
      • +16 more
      Jan 18, 2023

      Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, High Grade Endometrioid Ovarian Cancer Trial in Guangzhou (Fluzoparib

      Not yet recruiting
      • Ovarian Cancer
      • +4 more
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Cetntre
      Sep 25, 2023

      BRCA1 Hereditary Breast and Ovarian Cancer Syndrome Trial in Barretos (Doxorubicin, Carboplatin, Paclitaxel)

      Completed
      • BRCA1 Hereditary Breast and Ovarian Cancer Syndrome
      • Barretos, SP, Brazil
        Barretos Cancer Hospital
      Dec 25, 2022

      BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Columbus (Informational Intervention, Survey Administration)

      Recruiting
      • BRCA1 Gene Mutation
      • BRCA2 Gene Mutation
      • Informational Intervention
      • Survey Administration
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Mar 2, 2022

      Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in France

      Completed
      • Epithelial Ovarian Cancer
      • +2 more
        • Agen, France
        • +136 more
        Dec 12, 2022

        Predictive Immune Biomarkers of Response to PAPR Inhibitors

        Recruiting
        • Ovarian Cancer
          • Seoul, Korea, Republic of
            Yonsei University Health System, Severance Hospital
          Nov 25, 2022

          Triple Negative Breast Tumors, Triple Negative Breast Cancer, Breast Tumors Trial (Pembrolizumab, Paclitaxel, Carboplatin)

          Not yet recruiting
          • Triple Negative Breast Neoplasms
          • +7 more
          • (no location specified)
          Aug 1, 2022

          BRCA-Mutated Ovarian Carcinoma, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Houston (Chemotherapy, Olaparib, Therapeutic

          Recruiting
          • BRCA-Mutated Ovarian Carcinoma
          • +30 more
          • Houston, Texas
            M D Anderson Cancer Center
          May 27, 2022

          Sarcopenia Trial in Majadahonda (Branched chain amino acids (BRCA))

          Completed
          • Sarcopenia
          • Branched chain amino acids (BRCA)
          • Majadahonda, Madrid, Spain
            Jose Luis Calleja
          Aug 27, 2019

          Prostate Cancer Trial in Toronto (MS3TMRI / TRUS Guided Biopsy)

          Recruiting
          • Prostate Cancer
          • MS3TMRI / TRUS Guided Biopsy
          • Toronto, Ontario, Canada
            Sunnybrook Odette Cancer Centre
          May 5, 2022